Sentinus LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.9M Buy
2,071
+894
+76% +$906K 0.17% 114
2025
Q4
$1.27M Buy
1,177
+354
+43% +$338K 0.12% 148
2025
Q3
$628K Buy
823
+55
+7% +$40.9K 0.14% 105
2025
Q2
$599K Buy
768
+52
+7% +$40.4K 0.15% 108
2025
Q1
$591K Buy
716
+142
+25% +$118K 0.17% 96
2024
Q4
$443K Buy
574
+55
+11% +$45.5K 0.13% 115
2024
Q3
$460K Buy
519
+77
+17% +$69.2K 0.14% 118
2024
Q2
$401K Buy
442
+21
+5% +$16.8K 0.13% 117
2024
Q1
$328K Buy
+421
New +$300K 0.12% 123

Other funds holding LLY

Sentinus LLC's LLY Position: Q1 2026 in Review

Sentinus LLC increased its Eli Lilly (LLY) stake by 76% in Q1 2026, buying an estimated $906K and bringing the position to 2,071 shares worth $1.9M. The position accounts for 0.17% of the portfolio, ranked #114.

Sentinus LLC first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sentinus LLC held 2,071 shares of Eli Lilly worth $1.9M as of Q1 2026.
  • Sentinus LLC bought 894 Eli Lilly shares in Q1 2026, an estimated $906K.
  • Eli Lilly made up 0.17% of Sentinus LLC's portfolio in Q1 2026, its #114 holding.
  • Sentinus LLC first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sentinus LLC's 13F filing for Q1 2026, filed 6 May 2026.